Company / Working Capital per Share
Moleculin Biotech, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$20.95
FY2025
5-year range
-$0.07 / $20.95
FY2021-FY2025
Trend
+28387.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed +28388% YoY in FY2025, a notable deviation from the 8-year average annual change of +3628%.
Based on SEC 10-K filings.
20.95 in FY2025 with a 5-year CAGR of +62.1%.
Improved from $10.20 to $20.95 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +62.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 28387.7% year-over-year.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.95 | +28387.7% |
| FY2024 | -$0.07 | -100.7% |
| FY2023 | $10.20 | - |
| FY2022 | - | - |
| FY2021 | $5.97 | +218.7% |
| FY2020 | $1.87 | +439.1% |
| FY2019 | $0.35 | +82.1% |
| FY2018 | $0.19 | -61.9% |
| FY2017 | $0.50 | -14.0% |
| FY2016 | $0.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026